RxDoctor Payments Data

Shrujal Baxi

Medical Oncology · New York, NYNPI 1407003742

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 55.5% of the total. That places this record below the midpoint for medical oncology clinicians in NY, where the typical reported total is $4,912.

$6,138in general payments, 2019–2025

Across 7 payments — averaging $876.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$3K
  • Astrazeneca UK Limited$3K
  • Varian Medical Systems, Inc.$29
$538,028in research payments, 2019–2025

Across 3 payments — averaging $179,343 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$538K

What the payments were for

  • Consulting fees$2,70044%
  • Travel & lodging$3,30754%
  • Food & beverage$1312%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,138 in reported general payments places this provider in the 50th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York →

Other medical oncology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →